Literature DB >> 7545078

Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus.

M Ohlin1, B Plachter, V A Sundqvist, P G Steenbakkers, J M Middeldorp, C A Borrebaeck.   

Abstract

The lower matrix protein (pp65) is a major product of many laboratory strains of cytomegalovirus (CMV). It is thus an integral part of many CMV serological assays based on native antigen. Recombinant fragments of pp65 have previously been investigated for their usefulness in more-defined assays. The latter antigens have, however, failed to develop a positive response with serum samples derived from a substantial number of infected individuals. Here we show that the human humoral immune response to CMV pp65 is highly diverse and recognizes at least seven distinct but in some cases partly overlapping epitopes. Most of these epitopes could not be mimicked by any of the investigated recombinant or synthetic antigens. Furthermore, when we investigated the ability of human CMV-seropositive serum samples to block the reactivity of pp65-specific antibodies recognizing five different epitopes within pp65, it was evident that several sera did not contain significant levels of antibodies against any of these or overlapping structures. It was thus concluded that the antibody response against CMV pp65 is weak in some CMV-infected individuals, making this antigen unsuitable for use alone in serological screening systems for CMV infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545078      PMCID: PMC170154          DOI: 10.1128/cdli.2.3.325-329.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

1.  Large-scale screening of human sera with cytomegalovirus recombinant antigens.

Authors:  M P Landini; M X Guan; G Jahn; W Lindenmaier; M Mach; A Ripalti; A Necker; T Lazzarotto; B Plachter
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

2.  Antibody response to virus-encoded proteins after cytomegalovirus mononucleosis.

Authors:  K Hayes; C Alford; W Britt
Journal:  J Infect Dis       Date:  1987-10       Impact factor: 5.226

3.  Immunofluorescence for detection of antibodies against human cytomegalovirus-induced membrane antigens.

Authors:  J M Middeldorp; J Jongsma; T H The
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

4.  Lymphocyte proliferation and IgG production with herpesvirus antigens in solid phase.

Authors:  P Ljungman; B Wahren; V A Sundqvist
Journal:  J Virol Methods       Date:  1985-12       Impact factor: 2.014

5.  Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus.

Authors:  A Irmiere; W Gibson
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

6.  The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties.

Authors:  G Jahn; B C Scholl; B Traupe; B Fleckenstein
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

7.  Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus.

Authors:  B Rüger; S Klages; B Walla; J Albrecht; B Fleckenstein; P Tomlinson; B Barrell
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

8.  Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients.

Authors:  J A Zaia; S J Forman; Y P Ting; E Vanderwal-Urbina; K G Blume
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

9.  Procaryotic expression of phosphorylated tegument protein pp65 of human cytomegalovirus and application of recombinant peptides for immunoblot analyses.

Authors:  B Plachter; S Klages; S Hagelmann; W Britt; M P Landini; G Jahn
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

10.  Human monoclonal antibodies recognize early and late viral proteins of human cytomegalovirus.

Authors:  H Alexander; J Harpprecht; H G Podzuweit; P Rautenberg; W Müller-Ruchholtz
Journal:  Hum Antibodies Hybridomas       Date:  1994
View more
  2 in total

1.  Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays.

Authors:  A E Greijer; J M van de Crommert; S J Stevens; J M Middeldorp
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

2.  CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors.

Authors:  Qingda Meng; Davide Valentini; Martin Rao; Ernest Dodoo; Markus Maeurer
Journal:  Sci Rep       Date:  2018-11-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.